TSE:TH Theratechnologies (TH) Stock Price, News & Analysis C$1.65 +0.01 (+0.61%) (As of 09/6/2024 ET) Add Compare Share Share Today's RangeC$1.63▼C$1.6750-Day RangeC$1.64▼C$2.1652-Week RangeC$1.27▼C$4.45Volume22,430 shsAverage Volume27,301 shsMarket CapitalizationC$75.87 millionP/E RatioN/ADividend Yield3.76%Price TargetC$5.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades Get Theratechnologies alerts: Email Address Theratechnologies MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside233.3% UpsideC$5.50 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.42Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.44 out of 5 stars 3.3 Analyst's Opinion Consensus RatingTheratechnologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageTheratechnologies has received no research coverage in the past 90 days.Read more about Theratechnologies' stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for TH. Previous Next 1.7 Dividend Strength Dividend LeadershipTheratechnologies is a leading dividend payer. It pays a dividend yield of 3.76%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthTheratechnologies does not have a long track record of dividend growth.Read more about Theratechnologies' dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TH. Previous Next 2.5 News and Social Media Coverage News SentimentTheratechnologies has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Theratechnologies this week, compared to 1 article on an average week.MarketBeat Follows2 people have added Theratechnologies to their MarketBeat watchlist in the last 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Theratechnologies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.29% of the stock of Theratechnologies is held by insiders.Percentage Held by Institutions51.21% of the stock of Theratechnologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Theratechnologies' insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Theratechnologies is -9.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Theratechnologies is -9.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioDue to a projected decrease in earnings for Theratechnologies, their PEG ratio cannot be calculated.Read more about Theratechnologies' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm PressEx-CIA Advisor: “This is How Kamala will Rig the Election”A former CIA advisor with close ties to the White House… Has just released this shocking expose on Kamala’s plan to stop Trump. Every American needs to prepare now…Click here now and learn how to prepare. About Theratechnologies Stock (TSE:TH)Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its pipeline products include F8 Formulation that is in Phase 2b/3 clinical trials for studying tesamorelin for the treatment of nonalcoholic steatohepatitis; multi -dose pen injector for the administration of tesamorelin; SORT1+ Technology Platform for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; Sudocetaxel Zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company was incorporated in 1993 and is headquartered in Montreal, Canada.Read More TH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TH Stock News HeadlinesSeptember 5 at 10:30 PM | finance.yahoo.comTheratechnologies Inc. (THTX)September 3, 2024 | americanbankingnews.comTheratechnologies (TSE:TH) Shares Pass Below 50-Day Moving Average of $1.92September 7, 2024 | Golden Crest (Ad)Biden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.August 18, 2024 | wsj.comCOSCIENS Biopharma Inc.July 24, 2024 | theglobeandmail.comClosing Bell: Theratechnologies flat on Tuesday (TH)May 23, 2024 | finance.yahoo.comTheratechnologies Up Near 5% In US After Hours On Data Related To Its Lead Investigational Peptide Drug Conjugate CandidateApril 14, 2024 | theglobeandmail.comTheratechnologies: Top 10 Undervalued Biotechnology Industry Stocks (TH)April 10, 2024 | msn.comU.S. Index Futures Show Mixed Trend Ahead of Key Inflation Data Release, Oil Prices Edge HigherSeptember 7, 2024 | Golden Crest (Ad)Biden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.April 9, 2024 | stockhouse.comTheratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology(TM) Oncology PlatformMarch 11, 2024 | msn.comNurse-Led Strategy Reduces Cardiovascular Risk Factors for People With HIVFebruary 27, 2024 | morningstar.comTheratechnologies Shares Sink Premarket After FDA Refusal to File LetterFebruary 27, 2024 | seekingalpha.comTheratechnologies stock plunges after FDA denies review of Trogarzo sBLAFebruary 23, 2024 | finance.yahoo.comTheratechnologies Full Year 2023 Earnings: Misses ExpectationsFebruary 21, 2024 | finance.yahoo.comTheratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 GuidanceFebruary 21, 2024 | markets.businessinsider.comHere's what Wall Street expects from Theratechnologies's earnings reportFebruary 20, 2024 | benzinga.com7THTX : Theratechnologies Earnings PreviewFebruary 20, 2024 | finance.yahoo.comTheratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of ActionSee More Headlines Receive TH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/10/2024Today9/07/2024Next Earnings (Estimated)9/24/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryRestaurants, Hotels, Motels Current SymbolTSE:TH CUSIPN/A CIKN/A Webwww.theratech.com Phone+1-514-3367800FaxN/AEmployees820Year FoundedN/APrice Target and Rating Average Stock Price TargetC$5.50 High Stock Price TargetC$5.50 Low Stock Price TargetC$5.50 Potential Upside/Downside+233.3%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.18) Trailing P/E RatioN/A Forward P/E Ratio40.24 P/E Growth-8.5Net IncomeC$-7,000,000.00 Net Margins-8.47% Pretax MarginN/A Return on Equity-1,116.86% Return on Assets5.15% Debt Debt-to-Equity Ratio562.07 Current Ratio1.10 Quick Ratio0.64 Sales & Book Value Annual SalesC$82.57 million Price / Sales0.92 Cash FlowC$0.44 per share Price / Cash Flow3.76 Book ValueC($0.50) per share Price / Book-3.30Miscellaneous Outstanding Shares45,980,000Free FloatN/AMarket CapC$75.87 million OptionableNot Optionable Beta1.75 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Paul Lévesque (Age 59)President, CEO & Director Comp: $1.6MMr. Philippe Dubuc M.B.A. (Age 57)MBA, Senior VP & CFO Comp: $587.17kMr. Jocelyn Lafond L.L.M. (Age 56)LL.B., General Counsel & Corporate Secretary Comp: $429.6kDr. Christian Marsolais Ph.D. (Age 61)Senior VP & Chief Medical Officer Comp: $590.29kMr. John Leasure (Age 59)Global Commercial Officer Comp: $571.68kHon. Andre Dupras M.Sc. (Age 60)Vice President of Human Resources More ExecutivesKey CompetitorsMaple Gold MinesCVE:MGMMount Logan CapitalTSE:MARCENTRIC HEALTHTSE:CHHJaxon MiningCVE:JAXPacific Paradym EnergyCVE:PPEView All CompetitorsInsidersDale WeilBought 36,200 shares on 11/1/2023Total: C$49,956.00 ($1.38/share)Joseph ArenaBought 10,000 shares on 10/30/2023Total: C$9,250.00 ($0.93/share)Dawn SvoronosBought 15,800 shares on 10/27/2023Total: C$21,646.00 ($1.37/share)Philippe DubucBought 8,000 shares on 10/27/2023Total: C$10,855.20 ($1.36/share)View All Insider Transactions TH Stock Analysis - Frequently Asked Questions How have TH shares performed this year? Theratechnologies' stock was trading at C$2.14 at the beginning of 2024. Since then, TH stock has decreased by 22.9% and is now trading at C$1.65. View the best growth stocks for 2024 here. How were Theratechnologies' earnings last quarter? Theratechnologies Inc. (TSE:TH) announced its quarterly earnings data on Wednesday, July, 10th. The company reported $0.03 earnings per share (EPS) for the quarter. The company earned $30 million during the quarter. Theratechnologies had a negative net margin of 8.47% and a negative trailing twelve-month return on equity of 1,116.86%. How do I buy shares of Theratechnologies? Shares of TH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Theratechnologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Theratechnologies investors own include Stars Group (TSGI), BCE (BCE), ProMetic Life Sciences (PLI), Teranga Gold (TGZ), Endeavour Mining (EDV) and Nemaska Lithium (NMX). This page (TSE:TH) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theratechnologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theratechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.